Researchers have found in a new study that predialytic Oral Nutritional Supplement (ONS) administration may help improve ...

On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ...

In the Phase III CALYPSO trial, eneboparatide demonstrated statistical significance in achieving albumin-adjusted serum calcium normalization while eliminating the need for active vitamin D and oral ...

With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...

Dr. Bhavna Tandon, Chief Scientific Officer at Brown Foods, unveils a test-tube full of UnReal Milk — the world’s first lab-made whole cow milk, at Brown Foods’ lab in Boston, MA.

Urinalysis is one of the most frequently ordered diagnostic tests, critical for identifying conditions like urinary tract infections (UTIs), kidney disease, and diabetes. However, traditional dipstick ...

AstraZeneca's eneboparatide met its Phase 3 trial goal for chronic hypoparathyroidism, while the EU approved Imfinzi for ...

This marks the first time in 25 years that plasma is being used to create medicines for NHS patients, reducing the need for ...

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...

In a groundbreaking development, the first NHS patients in a generation have begun receiving life-saving plasma from UK ...

The NHS said it is on track to provide 25% of its immunoglobulin needs by the end of the year, with plans to increase this to 30-35% by 2031, and 80% of albumin by 2026. Health minister Baroness ...